Do you 'need' or just 'want' that new diagnostic imaging device?

Physicians should evaluate which options best meet the needs of their practices.

Visualizing the optic disc with D-EYE

Rachel Curtis, MD, a fourth-year resident at Queen's University, Kingston, Ontario, Canada, discusses the highlights from a study comparing a smartphone-compatible device versus traditional direct ophthalmoscopy in teaching medical students how to complete an optic nerve examination.

Tool offers ultra-rapid cooling for intravitreal injections

Precision injection device can improve patient and physician experiences.

Aerie COO: Expanding innovation of glaucoma therapeutics

February 06, 2021

Tom Mitro, president, COO of Aerie Pharmaceuticals, discusses the key highlights from an industry panel discussion titled "Innovate without borders," held during the Glaucoma 360 New Horizons Forum, including the company's role in expanding into the global glaucoma therapeutics market.

Glaukos COO shares product updates, 2021 pipeline

January 31, 2021

Glaukos Corporation's COO Chris Calcaterra gives an update on the company's latest 24-month phase 2b data for its iDose TR sustained-release travoprost implant, next steps for securing FDA approval, and his outlook for 2021.